Justin Galovich, MD
Vascular Surgery · Honolulu, HINPI 1033303524
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Cook Incorporated at 37.1% of the total. Reporting peaked in 2023 at $6,090 and has fallen 95.5% since, to $273 in 2025.
Across 63 payments — averaging $206.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$5K
- Cook Medical LLC$3K
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$2K
- Endologix LLC$373
- Medtronic$304
- plus $853 from 11 others
What the payments were for
- Speaking & faculty fees$4,18032%
- Travel & lodging$5,38241%
- Food & beverage$3,47427%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 4 | $4,843 |
| Cook Medical LLC | 8 | $2,921 |
| W. L. Gore & Associates, Inc. | 8 | $1,986 |
| Silk Road Medical, Inc. | 15 | $1,757 |
| Endologix LLC | 5 | $373 |
| Medtronic | 5 | $304 |
| Dilon Technologies, Inc. | 3 | $210 |
| Abbott | 2 | $121 |
| Shockwave Medical, Inc | 3 | $115 |
| Penumbra, Inc. | 1 | $103 |
| Lemaitre Vascular, Inc. | 2 | $90 |
| Johnson & Johnson | 1 | $87 |
| Getinge USA Sales, LLC | 2 | $42 |
| Inari Medical, Inc. | 1 | $28 |
| Inspiremd Ltd | 1 | $27 |
| Bard Peripheral Vascular, Inc. | 1 | $17 |
| Merit Medical Systems Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zenith Alpha$2,500
- Cook$2,022
- ENROUTE Transcarotid Neuroprotection System$1,711
- Formula 418$1,680
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,563
- ENROUTE Transcarotid Stent$1,554
- Lunderquist$1,253
- ENHANCE Transcarotid Peripheral Access Kit$715
- ENROUTE .014 Guidewire$715
- GORE TAG Thoracic Branch Endoprosthesis$326
- Zenith Spiral-Z$176
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$157
- HemoBlast Bellows$128
- Torus Stent Graft System$128
- ENDOCROSS Device$128
- ENDURANT IIS$123
- Penumbra System$103
- Indigo$103
- JETi Peripheral Catheter$103
How this compares
$13,035 in reported general payments places this provider in the 80th percentile of 25 vascular surgery providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $12,747 |
| ClopidogrelClopidogrel Bisulfate | 22 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $87 | $12,74716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 25 vascular surgery providers in Hawaii.
Other vascular surgery in Honolulu
- Peter SchneiderHonolulu$4.8M
- Nathan ItogaHonolulu$21K
- Tanner KimHonolulu$13K
- Jessica GreenHonolulu$4K
- Elna MasudaHonolulu$2K
- Nicolas NelkenHonolulu$2K
- Selena GossHonolulu$1K
- Michael CapsHonolulu$967
- James GreigHonolulu$886
- David WongHonolulu$225
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.